Phase II study of R-CEOP 1-8 for aggressive non-Hodgkin lymphoma in elderly patients

被引：0
|
作者：
Marelli, M.
Bascialla, L.
Chini, C.
Proserpio, I
Gueli, R.
Pinotti, G.
机构：
[1] Azienda Osped Osped Circolo, UO Oncol Med, Varese, Italy
[2] Fdn Macchi, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI57 / XI57
页数：1
相关论文
共 50 条
  • [31] Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
    Barr, Paul M.
    Lazarus, Hillard M.
    Cooper, Brenda W.
    Schluchter, Mark D.
    Panneerselvam, Ashok
    Jacobberger, James W.
    Hsu, Jack W.
    Janakiraman, Nalini
    Simic, Aleksandra
    Dowlati, Afshin
    Remick, Scot C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (08) : 484 - 487
  • [32] Pharmacokinetic study of RCHOP protocol in elderly patients with non-Hodgkin lymphoma
    Baudry, Elodie
    Coudrec, Anne Laure
    Chaibi, Pascal
    Bret, Fanny
    Djebnoun, Sara
    Weill, Sophie
    Huguet, Samuel
    Boyault, Alexandre
    Lokiec, Francois
    Rezai, Keyvan
    CANCER RESEARCH, 2017, 77
  • [33] Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study
    Macpherson, N.
    Belch, A.
    Taylor, M.
    Sutherland, J.
    Czaykowski, P.
    Connors, J.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1327 - 1332
  • [34] Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma
    Coiffier, B
    TUMORI, 2002, 88 (01) : S26 - S28
  • [35] Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma
    Coiffier, B
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 18 - 22
  • [36] Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
    Stefoni, V
    Tani, M
    Alinari, L
    Marchi, E
    Gabriele, A
    Musuraca, G
    Fina, M
    Pileri, S
    Baccarani, M
    Zinzani, PL
    ANNALS OF ONCOLOGY, 2005, 16 : 102 - 102
  • [37] Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study
    Leivonen, Suvi-Katri
    Jorgensen, Judit
    Larsen, Thomas Stauffer
    Pasanen, Annika
    Karjalainen-Lindsberg, Marja-Liisa
    Toldbod, Helle M.
    d'Amore, Francesco
    Leppa, Sirpa
    BLOOD, 2019, 134
  • [38] Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
    Zinzani, PL
    Tani, M
    Alinari, L
    Molinari, AL
    Stefoni, V
    Visani, G
    Gentilini, P
    Guardigni, L
    Fina, M
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1449 - 1454
  • [39] Outcome of Hodgkin's lymphoma and aggressive non-Hodgkin lymphoma patients refractory to salvage chemotherapy
    Castagna, L.
    Bramanti, S.
    Balzarotti, M.
    Giordano, L.
    Michieli, M.
    Anastasia, A.
    Magagnoli, M.
    Sarina, B.
    Todisco, E.
    Mazza, R.
    Nozza, A.
    Ibatici, A.
    Santoro, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S249 - S249
  • [40] Phase II study of rituximab in combination with CHOP chemotherapy and GMCSF in patients with previously untreated aggressive non-Hodgkin's lymphoma.
    Venugopal, P
    Gregory, SA
    Wooldridge, J
    Yunus, F
    Adler, S
    Shammo, J
    Enschede, S
    O'Brien, T
    Franson, P
    Porter, C
    BLOOD, 2002, 100 (11) : 314B - 314B
12345